13F filer · CIK 1663801
Bill & Melinda Gates Foundation
SEATTLE, WA · filing since Q4 2020 · last filing Nov 14, 2024
Reported value
$43.5M
+$3.3M vs prior
Positions
5
New / sold out
0 / 0
Added / reduced
0 / 1
Turnover
0.0%
buys $0 · sells $84.6K
Top-10 weight
100.0%
Biggest buys vs Q2 2024
No new or increased positions this quarter.
Biggest sells vs Q2 2024
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Reduced | CUREVAC N V | -28,771 | -1.8% | $-84.6K |
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q3 2024
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | BIONTECH SESPONSORED ADS | 148,674 | $17.7M | 40.59% |
| 2 | VIR BIOTECHNOLOGY INCCOM | 1,559,142 | $11.7M | 26.84% |
| 3 | EXSCIENTIAADS | 1,590,909 | $7.8M | 17.85% |
| 4 | CUREVAC N VCOM | 1,568,866 | $4.6M | 10.60% |
| 5 | BUTTERFLY NETWORK INCCOM CL A | 1,011,003 | $1.8M | 4.11% |